George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTekCapital Regulatory News (TEK)

Share Price Information for TekCapital (TEK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 8.35
Bid: 8.00
Ask: 8.70
Change: 0.20 (2.45%)
Spread: 0.70 (8.75%)
Open: 8.25
High: 8.35
Low: 8.25
Prev. Close: 8.15
TEK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Successful Production and Testing of µSaltTM

4 Jan 2017 07:00

RNS Number : 2511T
Tekcapital plc
04 January 2017
 
 

Dissemination of a Regulatory Announcement that contains inside information according to REGULATION (EU) No 596/2014 (MAR)

 

Tekcapital plc

("Tekcapital" or "the Company")

 

Successful Production and Independent Testing of µSaltTM

 

Tekcapital plc (AIM: TEK), an international provider of technology and intellectual property services, announces a successful test-production and independent taste testing of µSaltTM, its proprietary, low-sodium salt product.

 

Successful Taste Tests

Tekcapital has manufactured test quantities of µSaltTM in a current Good Manufacturing Practice ("cGMP") facility regulated by the US Food and Drug Administration. Test quantities of µSaltTM were then supplied to several organisations for independent testing and evaluation. The results of the study indicate that a taste test of traditional potato chips versus those salted with µSaltTM, with approximately 40% less sodium than traditional potato chips, yielded no statistically significant difference in perceived salt flavour.

 

Technology Background

In 2016, Tekcapital announced that it acquired US patent #8,900,650 B1 for low-sodium salt compositions, which has the potential to enable the commercialisation of a 1:1 replacement for regular salt in a variety of applications including table-top, dry snacks such as chips and crisps, popcorn, cereals, and other dry surface applications that have salt in spice mixes.

 

Regular 'table salt' is not readily soluble in saliva because of its high density and large particles size. When regular salt particles are sprinkled on foods for immediate consumption or during further processing, they tend to provide low-intensity and long-lasting spotty salty tastes. The µSaltTM technology aims to deliver an improved dissolution, providing an equally salty taste as table salt with lower salt concentrations.

 

This innovative 'microsalt' does not contain substitutes like calcium, potassium or magnesium salts, which can impart the bitter taste that is typical of many existing low-sodium salt products. Furthermore, these nano particles dissolve faster and are tasted faster by the consumer, thereby allowing for the reduction of the concentration of salt in dry snacks where salt and spices are applied to the surface.

 

Key features of a commercialised version of this salt preparation would include, but may not be limited to, co-blending with spices, flavours, colours and flow agents and increasing salt dispersion while enhancing salt sensation in the mouth.

 

Market Potential

According to market research firm IBISWorld Inc., sales of table salt in the United States in 2013 were approximately $598.7 million1. Based on the recently completed results from an independent university test, the Directors believe that its µSaltTM low-sodium technology could enable food companies to empower consumers to reduce sodium content in topical food applications without sacrificing taste. Furthermore, the Directors believe that this will be helpful in enabling individuals to seek to reduce their sodium consumption to less than or equal to 2,300 mg per day, as recommended in the 2015-2020 Dietary Guidelines for Americans2.

 

 

 

Commenting on the announcement, Clifford M. Gross, Ph.D., Executive Chairman of Tekcapital plc, said:

"We are excited to report that we have produced and tested our natural µSaltTM product and have found that it provides a level of taste similar to traditional salt, but with approximately 40% less sodium. If widely adopted, we believe that the potential positive impact to improving the health of consumers could be significant. We are currently in discussions with a number of leading companies regarding commercialisation of this exciting new product and we will update the market in due course."

 

 

 

 

For further information, please contact:

 

Tekcapital Plc

+1 305 200 3450

Clifford M. Gross, Ph.D.

info@tekcapital.com

 

Allenby Capital Limited (Nominated Adviser & Joint Broker)

 

+44 (0)20 3328 5656

Jeremy Porter / Alex Brearley

 

 

 

Optiva Securities Limited (Joint Broker)

+44 (0) 20 3137 1904

Jeremy King / Vishal Balasingham

jeremy.king@optivasecurities.com

 

 

Walbrook PR Ltd

+44 (0) 20 7933 8780

Paul Cornelius / Helen Cresswell / Sam Allen

tekcapital@walbrookpr.com

 

Notes

----------------------------------------------------

1. http://www.prweb.com/releases/2013/8/prweb11061887.htm 

2. http://www.fda.gov/Food/GuidanceRegulation/GuidanceDocumentsRegulatoryInformation/ucm494732.htm#ftn9

 

 

 

Tekcapital plc - The World's Largest University Network for Open Innovation

Tekcapital helps clients profit from new, university-developed intellectual properties. With our proprietary discovery search engine, linked to 4,500+ universities in 160 countries, coupled with expert scientific review, we provide a turn-key service to make it easy for clients to find and acquire the IP, analytics and technology transfer professionals they need to create a competitive advantage. Tekcapital plc is listed on the AIM market of the London Stock Exchange (AIM: symbol TEK) and is headquartered in Oxford, in the UK. For more information, please visit www.tekcapital.com

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
UPDUGUWWGUPMGMW
Date   Source Headline
26th Apr 20247:00 amRNSInnovative Eyewear Canadian Partnership
25th Apr 20247:00 amRNSInnovative Eyewear Patent Filings
18th Apr 20247:00 amRNSInnovative Eyewear Signs Brand Ambassador
17th Apr 20247:00 amRNSInnovative Eyewear Distribution Partnership
9th Apr 20247:00 amRNSPortfolio Company Update : Guident Ltd
5th Apr 20247:00 amRNSPortfolio Company Update : Guident Ltd
28th Mar 202410:20 amRNSNotification of Major Holdings
7th Mar 202411:15 amRNSNotification of Major Holdings
6th Mar 20247:00 amRNSIntellectual Property Update
29th Feb 20247:51 amRNSFundraising of £2.0 million
19th Feb 20247:00 amRNSPortfolio Company Update : Guident Ltd
15th Feb 202410:31 amRNSNotification of Major Holdings
15th Feb 20247:00 amRNSGuident Expands its Strategic Partnership
13th Feb 20242:24 pmRNSNotification of Major Holdings
1st Feb 20247:15 amRNSMicroSalt Admission to AIM First Day of Dealings
1st Feb 20247:01 amRNSNotice of Presentation on Investor Meet Company
24th Jan 20247:00 amRNSBellescura Plc - Disposal of Shares
12th Jan 20244:31 pmRNSLoan Agreement with Innovative Eyewear Inc
11th Jan 20247:00 amRNSInnovative Eyewear Patent Applications
9th Jan 20247:00 amRNSMicroSalt expand Placement Low Sodium Salt Shakers
22nd Dec 20237:00 amRNSAnnual Corporate & Strategy Update
14th Dec 20237:00 amRNSInnovative Eyewear Appoints Brand Ambassador
13th Dec 20237:00 amRNSInnovative Eyewear Update for Android ChatGPT App
12th Dec 20237:00 amRNSInnovative Eyewear,Inc. Global Licensing Agreement
17th Nov 20237:00 amRNSInnovative Eyewear Launches Upgraded Charging Dock
16th Nov 202312:12 pmRNSForm 8.3 - Belluscura PLC
1st Nov 20237:00 amRNSMicroSalt placement SaltMe! Crisps in MR Williams
19th Oct 20237:00 amRNSMicroSalt placement of SaltMe Low Sodium Crisps
17th Oct 20237:00 amRNSInnovative Eyewear Launches New Collection
16th Oct 20237:00 amRNSTakeover Code Form 8.3 - Belluscura plc
5th Oct 20237:00 amRNSBelluscura Update
5th Oct 20237:00 amRNSNotification of Major Holdings
3rd Oct 20238:00 amRNSMicroSalt Primary Bid Offer Files Schedule One
29th Sep 20238:00 amRNSHalf Yearly Report for period ending 30 June 2023
19th Sep 20237:00 amRNSMicroSalt Partnership with Weijohn Farms Group
13th Sep 20234:15 pmRNSNotification of Major Holdings
11th Sep 20237:00 amRNSInnovative Eyewear Announces Patent Filing
7th Sep 20237:00 amRNSMicroSalt files New Patent to Improve Baked Goods
6th Sep 20237:00 amRNSGuident Update
24th Aug 20237:00 amRNSPortfolio Company Update - Guident
17th Aug 20237:00 amRNSPortfolio Companies Update
14th Aug 20237:00 amRNSLucyd ChatGPT App Update for Smart Eyewear
1st Aug 20237:00 amRNSInnovative Eyewear Launches Lucyd Blueshift Lens
31st Jul 20237:00 amRNSMicroSalt commercial orders for SaltMe Crisps
30th Jun 20237:00 amRNSInnovative Eyewear Miami Fashion Week
28th Jun 20237:00 amRNSInnovative Eyewear Partnership with PRIVATO
26th Jun 20237:00 amRNSMicroSalt Expands U.S. Retail Network
22nd Jun 20231:38 pmRNSResults of Annual General Meeting
22nd Jun 20231:27 pmRNSInnovative Eyewear US$ 4.7Million Public Offering
20th Jun 20237:00 amRNSInnovative Eyewear Licensing Agreement for Reebok

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.